Risk factors associated with indeterminate gamma interferon responses in the assessment of latent tuberculosis infection in a high-incidence environment

Clinical and Vaccine Immunology

Volumn 19, Issue 8, 2012, Pages 1243-1247

  Oni, Tolu ^a,b   Gideon, Hannah P ^a   Bangani, Nonzwakazi ^a   Tsekela, Relebohile ^a   Seldon, Ronnett ^a   Wood, Kathryn ^a   Wilkinson, Katalin A ^a,c   Goliath, Rene T ^a   Ottenhoff, Tom H M ^d   Wilkinson, Robert J ^a,b,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CYTOKINE RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM BOVIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCAR; SOUTH AFRICA;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA;

EID: 84864542745     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00166-12     Document Type: Article

References (20)

1. Aabye MG, et al. 2009. The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS One 4:e4220. doi:10.1371/journal.pone.0004220.
2. Aichelburg MC, et al. 2009. Detection and prediction of active tuberculosis disease by a whole-blood interferon-γ release assay in HIV-1-infected individuals. Clin. Infect. Dis. 48:954-962.
3. Aichelburg MC, et al. 16 May 2012. Prognostic value of indeterminate interferon-γ release assay results in HIV-1-infection. J. Clin. Microbiol. doi:10.1128/JCM.01054-12.
4. Chapman ALN, et al. 2002. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 16:2285-2293. (Pubitemid 35449014)
5. Connell TG, et al. 2007. Enhanced ex vivo stimulation of Mycobacterium tuberculosis-specific T cells in human immunodeficiency virus-infected persons via antigen delivery by the Bordetella pertussis adenylate cyclase vector. Clin. Vaccine Immunol. 14:847-854.
6. Connell TG, et al. 2010. Indeterminate interferon-γ release assay results in children. Pediatr. Infect. Dis. J. 29:285-286.
7. Desem N, Jones SL. 1998. Development of a human gamma interferon enzyme immunoassay and comparison with tuberculin skin testing for detection of Mycobacterium tuberculosis infection. Clin. Diagn. Lab. Immunol. 5:531-536. (Pubitemid 28342883)
8. Diel R, Loddenkemper R, Nienhaus A. 2010. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a meta-analysis. Chest 137:952-968.
9. Franken KLMC, et al. 2000. Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expr. Purif. 18:95-99. (Pubitemid 30097778)
10. Getahun H, et al. 2011. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med. 8:e1000391. doi:10.1371/journal.pmed.1000391.
11. Hang NTL, et al. 2011. Analysis of factors lowering sensitivity of interferon-γ release assay for tuberculosis. PLoS One 6:e23806. doi:10.1371/journal.pone.0023806.
12. Kobashi Y, et al. 2009. Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice. Eur. Respir. J. 33:812-815.
13. + T-cells in HIV infection. Eur. Respir. J. 35:619-626.
14. Mahomed H, et al. 2006. Comparison of Mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection. Int. J. Tuberc. Lung Dis. 10:310-316.
15. Médecins Sans Frontierès. 2011. Summary: Khayelitsha 2001-2011 activity report - 10 years of HIV/TB care at primary health care level. Médecins Sans Frontierès, Sea Point, South Africa. http://www.msf.org.za/publication/summary-khayelitsha-activity-report-2001-2011.
16. Pai M, et al. 2005. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 293:2746-2755. (Pubitemid 40973379)
17. Papay P, et al. 2011. Predictors of indeterminate IFN-γ release assay in screening for latent TB in inflammatory bowel diseases. Eur. J. Clin. Invest. 41:1071-1076.
18. Raby E, et al. 2008. The effects of HIV on the sensitivity of a whole blood IFN-γ release assay in Zambian adults with active tuberculosis. PLoS One 3:e2489. doi:10.1371/journal.pone.0002489.
19. Rangaka MX, et al. 2007. Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection. Am. J. Respir. Crit. Care Med. 175:514-520. (Pubitemid 46354256)
20. Samandari T, et al. 2011. 6-Month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet 377:1588-1598.